Botanix Investor Centre

Botanix is an ASX-listed company (ASX:BOT), in a prime position for growth and to return value for shareholders. With deep expertise in dermatology and pharmaceutical product commercialisation, we are on track to disrupt some of the most lucrative global healthcare markets.

ASX: BOT | Share price


Feb 4, 2021
April 6, 2017

Share Registry

Our share and options registers are maintained by Automic Group (Automic).

Security holders who wish to update personal or contact information, elect to receive communications electronically, such as the company’s annual report or notice of meeting, or provide banking details can do so via the Automic website here and follow the prompts, or contact Automic (using the details below).

When updating information electronically or contacting Automic you will need your Security Reference Number (SRN) or your Holder Identification Number (HIN) and your postcode. Both numbers are on your Issuer Sponsored/CHESS statements.

The share registry’s contact details are:

p: 1300 288 664 (within Australia) +61 (0)2 9698 5414 (Overseas)

12 July 2022
December 9, 2019
September 17, 2019
January 31, 2019
November 15, 2018
August 13, 2018
April 9, 2018
November 13, 2017

Latest video

Investor Webinar Replay | 26 September 2023

Botanix (ASX: BOT) has received a communication from FDA in…

Dr Howie McKibbon appointed Chief Executive Officer

Botanix has announced the promotion of Dr Howie McKibbon to…

Bioshares Summit

Botanix is joining the biotech investment community at the 17th…

A$12.5 million institutional placement

Botanix has announced it has secured firm commitments for A$12.5…

Video | Investor Webinar

Botanix (ASX: BOT) hosted a webinar recently to update investors…

Investor Webinar Invitation

Botanix (ASX: BOT) is preparing to host an upcoming investor…

Analyst Report | 6 April 2023

Euroz Hartleys has published an analyst note, reporting on the…

Check out our latest investor presentation

Sign up to receive our latest news

Thank you! Your subscription has been confirmed. You'll hear from us soon.